Phase 3 Trial of Epanova for Hypertriglyceridemia - ONA
Links shared publicly online about this topic.
- 440total visits
Phase 3 Trial of Epanova for Hypertriglyceridemia - ONA
View full resource at oncologynurseadvisor.com
Tags: Pharma, Phase 3 Clinical Trial
Most Recently Shared on March 14, 2011 at 3:14 pm By:
Phase 3 Trial of Epanova for Hypertriglyceridemia http://goo.gl/fb/R4B5D
Top-line Results of the Pivotal Phase 3 Clinical Trial of TAK-085 in Japan for Treatment of Hypertriglyceridemia - Drugs.com MedNews
drugs.com — “- Takeda Pharmaceutical Company Limited (Osaka, Japan, Takeda ) and Pronova BioPharma ASA (Lysaker, Norway, Pronova ) today jointly announced the top-line resul” View full resource at drugs.com
Most Recently Shared on May 10, 2011 at 2:12 pm By:
Drugs and Devices OW OW Health
Top-line Results of the Pivotal Phase 3 Clinical Trial of TAK-085 in Japan for Treatment of Hypertriglycer... http://bit.ly/iUwxG7 #drug
Amarin's AMR101 Phase 3 ANCHOR Trial Meets all Primary and Secondary Endpoints with Statistically Significant Reductions in Triglycerides at Both 4 Gram and 2 Gram Doses and Statistically Significant Decrease in LDL-C - Drugs.com MedNews
drugs.com — “- Triglyceride levels decreased 21.5 and 10.1 from baseline versus placebo at 4 gram and 2 gram doses, respectively - LDL-C decreased at both doses within the p” View full resource at drugs.com
Most Recently Shared on April 18, 2011 at 2:15 pm By:
Drugs and Devices OW OW Health
Amarin's AMR101 Phase 3 ANCHOR Trial Meets all Primary and Secondary Endpoints with Statistically Signific... http://bit.ly/eofZrz #drug
Phase 3 Trial of Epanova for Hypertriglyceridemia - MPR
empr.com — “Omthera Pharmaceuticals announced the initiation of its Phase 3 EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial evaluating Epanova for the treatment of patients with very high triglycerides.” View full resource at empr.com
Most Recently Shared on March 14, 2011 at 3:48 pm By:
MPR News: Phase 3 Trial of Epanova for Hypertriglyceridemia: Omthera Pharmaceuticals announced the initiation of... http://bit.ly/i4FZ5e
Phase 3 study of Epanova for the treatment of hypertriglyceridemia - MPR
empr.com — “Omthera has announced it has reached an agreement with the FDA on a Special Protocol Assessment (SPA) for the design of its planned Phase 3 registration clinical trial of Epanova (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) for the treatment of hypertriglyceridemia.” View full resource at empr.com
Most Recently Shared on November 23, 2010 at 7:17 pm By:
MPR News: Phase 3 study of Epanova for the treatment of hypertriglyceridemia: Omthera has announced it has reach... http://bit.ly/iiS4B9
Omthera Pharmaceuticals Receives Special Protocol Assessment Agreement From The FDA For Its Pivotal Phase III EVOLVE Trial Of Epanova™
medicalnewstoday.com — “Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on a S” View full resource at medicalnewstoday.com
Most Recently Shared on November 23, 2010 at 2:22 pm By:
MNT Cholesterol News Health News
Omthera Pharmaceuticals Receives Special Protocol Assessment Agreement From The FDA For Its Pivotal Phase III EVOLVE T... http://mnt.to/3N3g
Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease
news-medical.net — “Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today announced that first patients were enrolled in the MARINE and ANCHOR Phase 3 clinical trials for AMR101, the Company's lead product candidate. These clinical trials are designed to demonstrate that AMR101 lowers triglyceride levels in patients with very high triglycerides (the MARINE Study) and high triglycerides in patients with mixed dyslipidemia being treated ” View full resource at news-medical.net
Most Recently Shared on January 12, 2010 at 8:57 am By:
Obesity News: Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease: Amar... http://twurl.nl/gx4uxx
Phase 3 study of AMR101 for the treatment of high triglycerides - MPR
empr.com — “Amarin Corporation announced the enrollment of patients in their two Phase 3 trials of AMR101 for the treatment of patients with high triglycerides.” View full resource at empr.com
Most Recently Shared on January 11, 2010 at 5:01 pm By:
MPR News: Phase 3 study of AMR101 for the treatment of high triglycerides: Amarin Corporation announced the enroll... http://bit.ly/4Fss8g
Advertisement
